Production, characterization and valuable applications of exopolysaccharides from marine Bacillus subtilis SH1

• Autorzy: Hassan S.W.M. , Ibrahim H.A.H.
• Języki publikacji: EN

Abstrakty

EN

Exopolysaccharides (EPSs) are high molecular weight polymers consisting of different sugar residues they are preferable for replacing synthetic polymers as they are degradable and nontoxic. Many microorganisms possess the ability to synthesize and excrete exopolysaccharides with novel chemical compositions, properties and structures to have potential applications in different fields. The present study attempt to optimize the production of EPS by marine Bacillus subtilis SH1 in addition to characterization and investigation of different valuable applications. Effect of medium type, incubation period and pH were studied using the one factor at a time experiments. It was shown that the highest productivity (24 gl⁻¹) of exopolysaccharides was recorded by using yeast malt glucose medium with pH 9 at the fourth day of incubation. Experimental design using Response Surface Methodology (RSM) was applied to optimize various nutrients at different concentrations. The finalized optimized medium contained (gl⁻¹) glucose (5), peptone (2.5), yeast extract (4.5) and malt extract (4.5) increased the production of EPS to 33.8 gl⁻¹ with1.4 fold increase compared to the basal medium. Chemical characterization of the extracted EPS showed that, FTIR spectra exhibited bands at various regions. Moreover, HPLC chromatogram indicated that the EPS was a heteropolysaccharide consisting of maltose and rhamnose. The study was extended to evaluate the potentiality of the extracted polysaccharides in different medical applications. Results concluded that, EPS exhibited antibacterial activity against Aeromonas hydrophila, Pseudomonas aeruginosa and Streptococcus faecalis and the highest antibacterial activity (7.8, 9 and 10.4 AU/ml) was against S. faecalis at 50, 100 and 200 mg/ml respectively. The EPS exhibited various degree of antitumor effect toward the tested cell lines (MCF-7, HCT-116 and HepG2). In addition, EPS exhibited antiviral activity at 500 μg/ml. The antioxidant capacity increased with increasing the concentrationof the sample. Scanning electron microscopic analysis showed that EPS had compact film-like structure, which could make it a useful in the future applications as in preparing plasticized film.

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2017
• Tom: 66
• Numer: 4
• Opis fizyczny: p.449-461,fig.,ref.

Twórcy

autor

Hassan S.W.M.

• Marine Microbiology Department, National Institute of Oceanography and Fisheries, Alexandria, Egypt

autor

Ibrahim H.A.H.

• Marine Microbiology Department, National Institute of Oceanography and Fisheries, Alexandria, Egypt

Bibliografia

• Abdel-Fattah M., M. Gamal-Eldeen, W.A. Helmy and MA.H. Esawy. 2012. Antitumor and antioxidant activities of levan and its derivative from the isolate Bacillus subtilis NRC1aza. Carbohydr. Polym. 89(2): 314–322.
• Abdul Razack S., V. Velayutham and V. Thangavelu. 2013. Influence of various parameters on exopolysaccharide production from Bacillus subtilis. Int. J. Chem. Tech. Res. CODEN (USA) 5(5): 2221–2228.
• Abou-Dobara M.I., A.A. El-Fallal, E. Toson, A. Abbas and F. El-Feky. 2014. Optimization of exopolysaccharides production by Bacillus subtilis. Pharmacol. 1: 140–148.
• Ahmed E.F., N.M. Mansour, W.A. Helmy, W.M. El-Senousy, M.M. El-Safty and M.A. Esawy. 2010. Production of an antiviral levan from novel honey Bacillus subtilis isolates. J. Gen. Engin Biotechnol. 8(1): 71–79.
• Anju P., N. Milind and D.K. Santosh. 2010. Hemolysin, protease, and EPS producing pathogenic Aeromonas hydrophila strain An4 shows antibacterial activity against marine bacterial fish pathogens. J. Mar. Biol. 10: 1–9.
• Bajaj B.K., H. Pangotra, M.A. Wani, P. Sharma and A. Sharma. 2009. Partial purification and characterization of a highly thermostable and pH stable endogluconase from a newly isolated Bacillus strain M-9. Ind. J. Chem. Technol. 16: 382–387.
• Berekaa M.M. 2014. Improved exopolysaccharide production by Bacillus licheniformis strain-QS5 and application of statistical experimental design. Int. J. Curr. Microbiol. App. Sci. 3(4): 876–886
• Bhaskar P.V. and N.B. Bhosle. 2005. Microbial extracellular polymeric substances in marine biogeochemical processes. Curr. Sci. 88(1): 45–53.
• Dahech I., K.S. Belghith, H. Belghith and H. Mejdoub. 2012. Partial purification of a Bacillus licheniformis levan sucrase producing levan with antitumor activity. Int. J. Biol. Macromolecul. 1(3): 329–335.
• Dargan D.J. 1998. Investigation of the anti HSV activity of candidate antiviral agents, pp. 387–405. In: Brown S.M. and A.R. MacLean (eds). Methods in Molecular Medicine. Humana Press Inc., Totowa.
• de Godoi A.M., L.C. Faccin-Galhardi, N. Lopes, D. Zendrini Rechenchoski, R.R. de Almeida, N.M. Pontes Silva Ricardo, C. Nozawa and R.E. Carvalho Linhares. 2014. Antiviral activity of sulfated polysaccharide of Adenanthera pavonina against Poliovirus in HEp-2 cells. Malaysian J. Microbiol. 8(3): 170–174.
• Cabral de Melo F.C.B., D. Borsato, J.B. Buzato and M.A.P.C. Celligoi. 2010. Levan from Bacillus subtilis natto: optimization of productivity using factorial design. J. Biotechnol. 150S: S378.
• EL-Masry M.H., A.I. Khalil, M.S. Hassouna and H.A.H. Ibrahim. 2002. In situ and in vitro suppressive effect of agricultural composts and their water extracts on some phytopathogenic fungi. World J. Microbiol. Biotechnol. 18: 551–558.
• Gangadevi V. and J. Muthumary. 2007. Preliminary studies on cytotoxic effect of fungal taxol on cancer cell lines. Afr. J. Biotechnol. 6: 1382–1386.
• Ghaly A.E., F. Arab, N.S. Mahmoud and J. Higgins. 2007. Production of levan by Bacillus licheniformis for use as a sealant in earthen manure storage structures. Amer. J. Biotechnol. Biochem. 3: 47–54.
• Hu J.M. and G.D. Hsiung. 1989. Evaluation of new antiviral agents: I. In vitro perspectives. Antiviral Res. 11(5–6):217–32.
• Hu C. and D.D. Kitts. 2000. Studies on the antioxidant activity of Echinacea root extract. J. Agric. Food Chem. 48: 1466–1472.
• Ikeda F., H. Shuto, T. Fukui and K. Tomita. 1982. An extracellular polysaccharide produced by Zoogloea ramigera 115. Eur. J. Biochem. 123: 437–445.
• Jane Y.W. and Y. Hsiu Feng. 2007. Characterization and flocculating properties of an extracellular biopolymer produced from Bacillus subtilis DYU1 isolate, Process Biochem. 42: 1114–1123.
• Kaura A., V. Gupta, G.S. Roy and M. Kaura. 2013. Spectrophotometric determination of chlorpheniramine maleate and phenylpropanolamine hydrochloride in dosage forms. Int. Curr. Pharmaceut. J. 2(5): 97–100.
• Kennedy A.F.D. and I.W. Sutherland. 1987. Analysis of bacterial exopolysaccharides. Biotechnol. Appl. Biochem. 9: 12–19.
• Kimmel S.A. and R.F. Roberts. 1998. Development of a growth medium suitable for exopolysaccharide production by Lactobacillus delbrueckii ssp. bulgaricus RR. Int. J. Food Microbiol. 40: 87–92.
• Ko S.-H., H.S. Lee, S.H. Park and H.K. Lee. 2000. Optimal conditions for the production of exopolysaccharide by marine microorganism Hahellachejuensis. Biotechnol. Bioprocess Eng. 5: 181–185.
• Kumar C.G., H.-S. Joo, J.-W. Choi, Y.-M. Koo and C.-S. Chang. 2004. Purification and characterization of an extracellular polysaccharide from haloalkalophilic Bacillus sp. I-450. Enzy. Microbiol. Technol. 34: 673–6681
• Lee I.Y., W.T. Seo, G. Kim, J. Kim, M.K. Ahn, S.G. Kwon and Y.H. Park. 1997. Optimization of fermentation conditions for production of exopolysaccharide from Bacillus polymyxa. Bioprocess Engin. 16: 71–75.
• Li Y., Li , Guo S. and Zhu H. 2016. Statistical optimization of culture medium for production of exopolysaccharide from endophytic fungus Bionectria ochroleuca and its antitumor effect in vitro. EXLI J. 15: 211–220.
• Lian, B., Y. Chen, J. Zhao, H.H. Teng, L.J. Zhu, and S. Yuan. 2008. Microbial flocculation by Bacillus mucilaginosus: applications and mechanisms. Bioresour Technol. 99: 4825–4831.
• Looijesteijn P.J., W.H.M. Van Casteren, R. Tuinier, D. Voragen and J. Hugenholtz. 2000. Influence of different substrate limitations on the yield, composition and molecular mass of exopolysaccharides produced by Lactococcuslactis subsp. cremoris in continuous cultures. J. Appl. Microbiol. 89(1): 116–122.
• Marshall V.M.E., E.N. Cowie and R.S. Moreton. 1995. Analysis and production of two exopolysaccharides from Lactococcus lactis subsp. cremoris LC330. J. Dairy Res. 62: 621–628.
• Matsuda M. and W. Worawattanamateekul. 1993. Structural analysis of a rhamnose-containing sulfated polysaccharide from a marine Pseudomonas. Nippon Suisan Gakkaishi 59: 875–878.
• Mengistu Y., C. Edward and J.R. Saunders. 1994. Continuous culture studies on the synthesis of capsular polysaccharide by Klebsiella pneumoniae K1. J. Appl. Bacteriol. 76: 424–430.
• Mukherjee A., S.A. Morosky, E. Delorme-Axford, N. Dybdahl- Sissoko, M.S. Oberste, T. Wang and C.B. Coyne. 2011. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog. 7(3): 100–111.
• Nanda A. and C.M. Raghavan. 2014. Production and characterization of exopolysacharides (EPS) from the bacteria isolated from Pharma lab sinks. Int. J. Pharm. Tech. Res. 6(4): 1301–1305.
• Nwodo U.U., E. Green and A.I. Okoh. 2012. Bacterial exo-polysaccharides: functionality and prospects. Int. J. Mol. Sci. 13: 14002–14015.
• Ohno N., N. Miura, M. Nakajima and T. Yadomae. 2000. Antitumor 1–3-glucan from cultured fruit body of Sparasis crispa. Boil Pharm. Bul. 23: 866–872.
• Orsod M., M. Joseph and F. Huyop. 2012. Characterization of exopolysaccharides produced by Bacillus cereus and Brachybacterium sp. isolated from Asian Sea Bass (Latescalcarifer). Mal. J. Microbiol. 8(3): 170–174.
• Patil S.V., G.A. Bathe, A.V. Patil, R.H. Patil and B.K. Salunkea. 2009. Production of bioflocculant exopolysaccharide by Bacillus subtilis. Advanced Biotech. 14–17.
• Philippis, R., M.C. Margheri, E. Pelosi and S. Ventura. 1993. Exopolysaccharide production by a unicellular cyanobacterium isolated from a hypersaline habitat. J. Appl. Phycol. 5: 387–394.
• Prathima P.C., V.K. Lule, S.K. Tomar and A.K. Singh. 2014. Optimization of Exopolysaccharide production by Lactococccus lactis NCDC 191 by Response Surface Methodology. Int. J. Curr. Microbiol. App. Sci. 3(5): 835–854.
• Rabha B., R.S. Nadra and B. Ahmed. 2012. Effect of some fermentation substrates and growth temperature on exopolysaccharide production by Streptococcus thermophilus BN1. Int. J. Biosci Biochem. Bioinfo. 2: 44–47.
• Raguenes G., P. Pignet, G. Gauthier, A. Peres, R. Christen, H. Rougeaux, G. Barbier and J. Guezennec. 1996. Description of a new polymer-secreting bacterium from a deep sea hydrothermal vent, Alteromonas macleodii subsp. fijiensis, and preliminary characterization of the polymer. Appl. Environ. Microbiol. 62: 67–73.
• Rawal P.M., P.B. Chauhan, H. Prajapati and M. Gahlout. Evaluation of cultivation condition for enhanced production of exopolysaccharide by bacterial isolate P 11 under submerged culture condition. Int. J. Adv. Res. Biol. Sci. 3(5): 183–190.
• Robert M., U. Zang, J. Chorover, L. Haumaier and K. Kalbitz. 2011. Stabilisation of extracellular polymeric substances (Bacillus subtilis) by adsorption to and co precipitation with Al forms. Geochimica et Cosmochimica Acta 75: 3135–3154.
• Rodrigues C. and N.B. Bhosle. 1991. Exopolysaccharide production by Vibrio fischeri, a fouling marine bacterium. Biofouling 4: 301–308.
• Sanlibaba P. and G.A. Çakmak. 2016. Exopolysaccharides production by lactic acid bacteria. Appl. Microbiol. 2(2): 1–5.
• Savadogo A., C.W. Savadogo, N. Barro, A.S. Ouattara and A.S. Traore. 2004. Identification of exopolysaccharides producing lactic acid bacteria from Burkino Faso fermented milk samples. Afr. J. Biotechnol. 3: 189–194.
• Shankar C.V.S., A. Malar and S.M.J. Punitha. 2010. Antimicrobial activity of marine bacteria associated with polychaetes. Bioresear Bull. 1: 24–28.
• Shukla V., M. Patel and S. Duggirala. 2015. Isolation, structural characterization and production of exopolysaccharide using batch culture by Bacillus spp. isolated from soil. Int. J. Res. Engin. Appl. Sci. 3(2): 102–109.
• Tallgren A.H., U. Airaksinen, R. von Weissenberg, H. Ojamo, J. Kuusisto and M. Leisola. 1999. Exopolysaccharide-producing bacteria from sugar beets. Sci. J. Damietta Faculty Sci. 3 (1): 11–21.
• Trabelsi L., N.H. M’sakni, H.B. Ouada, H. Bacha and S. Roudesli. 2009. Partial characterization of extracellular polysaccharides produced by Cyanobacterium arthrospira platensis. Biotechnol. Biopro. Engin. 14: 27–31
• Venkateswarulu T.C., K. Chakravarthy, R. Reddy, J. Babu and V. Kodali. 2016. Morphological and biochemical characterization of exopolysaccharide producing bacteria Isolated from dairy effluent indira M1. Pharm. Sci. Res. 8(2): 88–91.
• Vijayabaskar P., S. Babinastarlin, T. Shankar, T. Sivakumar and K.T.K. Anandapandian. 2011. Quantification and characterization of exopolysaccharides from Bacillus subtilis (MTCC 121). Adv. Biol. Res. 5: 71–76.
• Vijayan K., P.P. Srivastava and A.K. Awasthi. 2004. Analysis of phylogenetic relationship among five mulberry (Morus) species using molecular markers. Genome 47(3): 439–448.
• Vimala P. and D. Lalithakumari. 2003. Characterization of exopolysaccharide (EPS) produced by Leuconostoc sp. V 41. Asian J. Microbiol. Biotechnol. Environ. Sci. 5(2): 161–165.
• Wu C.Y., Z.C. Liang, C.P. Lu and S.H. Wu. 2008. Effect of carbon and nitrogen sources on the production and carbohydrate composition of exopolysaccharide by submerged culture of Pleurotus citrinopileatus. J. Food Drug Anal. 16: 61–67.
• Yada V., S.G. Prappulla, A. Jha and A. Poonia. 2011. A novel exopolysaccharide from probiotic Lactobacillus fermentum CFR 2195: production, purification and characterization. Biotechnol. Bioinf. Bioeng. 1(4): 415–421.
• You R.X., K.P. Wang, J.Y. Liu, M.C. Liu, L. Luo and Y. Zhang. 2011. A comparison study between different molecular weight polysaccharides derived from Lentinus edodes and their antioxidant activities in vivo. Pharm. Biol. 49: 1298–1305.
• Zandi K., M. Abbas Zadeh, K. Sartavi and Z. Rastian. 2007. Antiviral activity of Aloe Vera against herpes simplex virus type 2: An in vitro study. Afr. J. Biotechnol. 6: 1770–1773.

Identyfikatory

DOI

10.5604/01.3001.0010.7001